Literature DB >> 11040908

Erdheim-Chester disease: two cases of orbital involvement.

T G Sheidow1, D A Nicolle, J G Heathcote.   

Abstract

Erdheim-Chester disease (ECD) is an increasingly recognised form of fibro-inflammatory process characterised by xanthomatous histiocytes containing large amounts of ingested lipid, plasma cells, macrophages and Touton-type giant cells. Ophthalmic involvement in ECD has been reported in only 22 cases. We describe two patients, one presenting with diabetes insipidus and subsequently developing orbital pseudotumours and retroperitoneal fibrosis, the other presenting with exophthalmos and diplopia. The first patient was treated with cladribine and subsequently developed sudden onset of bilateral blindness while the second required radiation therapy for the retro-orbital process and developed radiation retinopathy. These cases typify the variable presentation and course in patients with ECD.

Entities:  

Mesh:

Year:  2000        PMID: 11040908     DOI: 10.1038/eye.2000.151

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

Review 1.  Treatment of Erdheim-Chester disease with cladribine: a rational approach.

Authors:  C Myra; L Sloper; P J Tighe; R S McIntosh; S E Stevens; R H S Gregson; M Sokal; A P Haynes; R J Powell
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

Review 2.  Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature.

Authors:  Jose Emilio Sanchez; Carmen Mora; Manuel Macia; Juan F Navarro
Journal:  Int Urol Nephrol       Date:  2010-03-16       Impact factor: 2.370

3.  FDG-PET in the Erdheim-Chester disease: its diagnostic and follow-up role.

Authors:  Emőke Steňová; Boris Steňo; Pavol Povinec; František Ondriaš; Jana Rampalová
Journal:  Rheumatol Int       Date:  2010-12-07       Impact factor: 2.631

Review 4.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  Cerebral Erdheim-Chester disease: case report and review of the literature.

Authors:  Stefan Weidauer; Sebastian von Stuckrad-Barre; Edgar Dettmann; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

6.  Local corticosteroid treatment of eyelid and orbital xanthogranuloma.

Authors:  Victor M Elner; Roni Mintz; Hakan Demirci; Adam S Hassan
Journal:  Trans Am Ophthalmol Soc       Date:  2005

7.  Erdheim-Chester disease in a child with MR imaging showing regression of marrow changes.

Authors:  Chan Uhng Joo; Yang Sim Go; In Hwan Kim; Chul Seong Kim; Sang Yong Lee
Journal:  Skeletal Radiol       Date:  2004-10-08       Impact factor: 2.199

8.  [Erdheim-Chester disease of the orbit with compressive optic neuropathy].

Authors:  K Manousaridis; J Casper; M P Schittkowski; H Nizze; R F Guthoff
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

9.  Erdheim-Chester disease: a case report.

Authors:  Esther M Hoffmann; Wibke Müller-Forell; Susanne Pitz; Herbert Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

Review 10.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.